Qube Research & Technologies (QRT)
SRRA

Qube Research & Technologies (QRT)’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-138,555
Closed -$7.62M – 3283
2022
Q2 		$7.62M Buy
138,555
+131,038
+1,743% +$6.88M 0.06% 365
2022
Q1 		$241K Buy
+7,517
New +$216K ﹤0.01% 1882

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SRRA Position: Q3 2022 in Review

Qube Research & Technologies (QRT) sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 138,555 shares — an estimated $7.62M sold.

Qube Research & Technologies (QRT) first reported a position in SRRA in Q1 2022 and held it in 2 quarters. The position peaked at $7.62M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Qube Research & Technologies (QRT) reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 138,555 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $7.62M.
  • Qube Research & Technologies (QRT) first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Sierra Oncology, Inc. Common Stock position peaked at $7.62M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.